Several listed companies respond to the issue of Nipah virus nucleic acid testing.

Kehua Biological responded on the Interactive Easy platform that its holding subsidiary, Tianlong Company, has Nipah virus test kits which can support key customs, disease control centers and other prevention and control points. Jiangjiang Biological's official WeChat account stated that due to the lack of specific symptoms in the early stages of Nipah virus infection, virus isolation and nucleic acid testing should be carried out early to confirm the diagnosis as soon as possible. The company mentioned that its Nipah virus nucleic acid testing kit has high sensitivity and rapid testing capabilities. Kapu Biological's official WeChat account indicated that the company has independently developed a Nipah virus nucleic acid testing kit, providing core technical support for global port quarantine and disease control monitoring with its precise testing performance. Shengxiang Biological expressed that in terms of rapid and accurate testing, it offers a "nucleic acid + sequencing" dual platform solution to support precise Nipah virus detection, providing technical support for epidemic monitoring and control. In addition, Shengxiang Biological's Nipah virus nucleic acid testing kit has obtained CE certification from the European Union. Antu Biological mentioned that its fully automatic nucleic acid purification and real-time fluorescence PCR analysis system AutoMolec 3000/1600 uses classical magnetic bead nucleic acid extraction and fluorescence quantitative PCR technology to provide fast testing support with the process of "sample in, result out". At the same time, some A-share companies have clarified rumors in the market, explicitly stating that they currently do not have any business layout related to Nipah virus.